Insider Trading History of Joyce Martin Joseph

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Joyce Martin Joseph since 2005. This trader's CIK number is 1300858. At the time of last reporting, Joyce Martin Joseph was the Director of Aldeyra Therapeutics, Inc.. (stock ticker symbol ALDX). Also see all insider trading activities at Aldeyra Therapeutics, Inc..

Note that in the past JOYCE MARTIN JOSEPH also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Aldeyra Therapeutics, Inc. (ALDX) by Joyce Martin Joseph

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 ALDX 4,323 $15,026 0 $0 0 $0
2019 ALDX 1,700 $9,963 0 $0 0 $0
2017 ALDX 4,444 $19,998 0 $0 0 $0
2014 ALDX 13,500 $103,948 0 $0 0 $0

Yearly summary of insider trading at Biosphere Medical Inc (BSMD) by Joyce Martin Joseph

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2006 BSMD 100,000 $1,000 0 $0 0 $0
2005 BSMD 5,000 $25,950 0 $0 0 $0


Insider trading activities at 2 companies by Joyce Martin Joseph:

1. Aldeyra Therapeutics, Inc. (ALDX)

2. Biosphere Medical Inc (BSMD)

Table 1. Insider trading of Aldeyra Therapeutics, Inc. (ALDX) by Joyce Martin Joseph

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-06-23 ALDX Buy 4,323 3.48 15,026
2019-09-12 ALDX Buy 1,700 5.86 9,963
2017-02-17 ALDX Buy 4,444 4.50 19,998
2014-08-07 ALDX Buy 1,000 3.95 3,948
2014-05-07 ALDX Buy 12,500 8.00 100,000

Table 2. Insider trading of Biosphere Medical Inc (BSMD) by Joyce Martin Joseph

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2006-06-01 BSMD Buy 100,000 .01 1,000
2005-11-01 BSMD Buy 5,000 5.19 25,950

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Joyce Martin Joseph (Director of Aldeyra Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.